Knoll Capital Management, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Knoll Capital Management, LLC reported 35 stock positions worth $148.4 million. Its top holding was Applied Therapeutics (APLT) at 17.5% of the portfolio, followed by Biohaven Pharmaceutical Hold (16.6%) and Aldeyra Therapeutics (ALDX, 12.2%). Compared with Q1 2024, it opened 1 new position and added to 2. The biggest buy was Altimmune (ALT, shares +98%).

Most Recent 13F
Q2 2026
Location
MIAMI, FL
CIK
0001325083
Portfolio Value
$148.4M (Q2 2024)
SEC Filing
0001104659-24-089595 ↗ filed Aug 14, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q1 2024: $160.7M Q1 2024 Q2 2024: $148.4M $148.4M Q2 2024 Q3 2024: $215.8M Q3 2024 Q4 2024: $155.3M Q4 2024 Q1 2025: $153.7M Q1 2025 Q2 2025: $140.7M Q2 2025 Q3 2025: $186.6M Q3 2025 Q4 2025: $218.0M Q4 2025 Q1 2026: $188.7M Q1 2026 Q2 2026: $214.3M Q2 2026

Holdings 35 stocks · $148.4M
APLT Applied Therapeutics Inc. 17.54% 5,574,687 $26.0M No change
BIOHAVEN PHARMACEUTICAL HOLD 16.62% 710,422 $24.7M Add +44.9%
ALDX Aldeyra Therapeutics Inc. 12.21% 5,475,516 $18.1M No change
AVDL Avadel Pharmaceuticals plc 5.68% 600,000 $8.4M No change
ALT Altimmune Inc. 5.03% 1,121,524 $7.5M Add +97.7%
ENTX Entera Bio Ltd. 4.81% 3,881,879 $7.1M No change
GLD SPDR Gold Shares 4.64% 32,000 $6.9M No change
SILV Silvercrest Metals Inc. 2.58% 470,000 $3.8M No change
KGC Kinross Gold Corp. 2.47% 440,000 $3.7M No change
AEM Agnico Eagle Mines Ltd. 2.45% 55,500 $3.6M No change
SA Seabridge Gold Inc. 2.27% 246,597 $3.4M No change
HOOKIPA PHARMA INC 2.20% 5,517,385 $3.3M No change
MAG Mag Silver Corp. 2.16% 275,000 $3.2M No change
WPM Wheaton Precious Metals Corp. 2.12% 60,000 $3.1M No change
FNV Franco-Nevada Corp. 2.00% 25,000 $3.0M No change
VRNA Verona Pharma Ltd. 1.95% 200,000 $2.9M No change
EQX Equinox Gold Corp. 1.94% 550,811 $2.9M No change
BAH Booz Allen Hamilton Holdings 1.35% 13,000 $2.0M No change
SIL Global X Silver Miners ETF 0.95% 45,175 $1.4M No change
OCUL Ocular Therapeutix Inc. 0.92% 200,400 $1.4M No change
SLV iShares Silver Trust 0.87% 48,500 $1.3M No change
V Visa Inc. Class A 0.86% 4,850 $1.3M No change
AGI Alamos Gold Inc. Class A 0.85% 80,000 $1.3M No change
PM Philip Morris International 0.68% 10,000 $1.0M No change
ITA iShares U.S. Aerospace & Def 0.68% 7,650 $1.0M No change
RGLD Royal Gold Inc. 0.64% 7,550 $945K No change
NOC Northrop Grumman Corp. 0.64% 2,165 $944K No change
MREO Mereo Biopharma Group PL-ADR 0.63% 260,470 $938K No change
CVS CVS Health Corp. 0.58% 14,500 $857K No change
DEO Diageo PLC-Sponsored ADR 0.57% 6,750 $851K No change
NEWP New Pacific Metals Corp. 0.49% 485,000 $728K No change
Orgenesis, Inc. 0.26% 634,738 $381K No change
SKE Skeena Resources Ltd. 0.14% 38,786 $208K No change
CRDL Cardiol Therapeutics Inc. Class A 0.14% 100,000 $202K New
IRD Opus Genetics Inc. filed as OCUPHIRE PHARMA INC 0.10% 100,000 $153K No change

Portfolio Sells Q1 2024 → Q2 2024
None this quarter.

Portfolio Buys Q1 2024 → Q2 2024
ALT Altimmune Inc. Add +97.7% 5.03% +1.43
CRDL Cardiol Therapeutics Inc. Class A New 0.14% +0.14
BIOHAVEN PHARMACEUTICAL HOLD Add +44.9% 16.62% −0.07

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026Amended 37$214.3MBIOHAVEN PHARMACEUTICAL HOLD, MGTX, PHYS, ALDX, OCUL
Q1 2026 37$188.7MBIOHAVEN PHARMACEUTICAL HOLD, PHYS, RGLD, MGTX, AEM
Q4 2025 33$218.0MALDX, BIOHAVEN PHARMACEUTICAL HOLD, NUVB, AVDL, GLD
Q3 2025 38$186.6MALDX, BIOHAVEN PHARMACEUTICAL HOLD, GLD, ENTX, MGTX
Q2 2025 38$140.7MALDX, BIOHAVEN PHARMACEUTICAL HOLD, ENTX, GLD, MGTX
Q1 2025 36$153.7MALDX, BIOHAVEN PHARMACEUTICAL HOLD, ENTX, GLD, MGTX
Q4 2024 35$155.3MBIOHAVEN PHARMACEUTICAL HOLD, ALDX, ENTX, VRNA, ALT
Q3 2024 36$215.8MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AGI, AVDL
Q2 2024 35$148.4MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AVDL, ALT
Q1 2024 34$160.7MAPLT, BIOHAVEN PHARMACEUTICAL HOLD, ALDX, AVDL, GLD